CoSci Med-Tech Co.
Overview
CoSci Med-Tech Co. is a China-based corporation specializing in medical technology investments. The company focuses on preclinical, clinical, and early-phase drug development, as well as industrialization research. It is a high-tech enterprise under the Beijing Zhongguancun Science and Technology Park, emphasizing innovation in the pharmaceutical sector. Established in 2003, CoSci Med-Tech Co. has been actively involved in the research and development of pharmaceutical technologies. The company has led significant investments, including a $17 million Series A financing in U.S.-based JDP Therapeutics, demonstrating its commitment to advancing medical technology. With a strategic focus on both domestic and international markets, CoSci Med-Tech Co. continues to play a pivotal role in the global medical technology investment landscape, fostering innovation and development in the healthcare sector.
Investment Focus
- Focus on medical technology
- Preference for early-phase drug development
- Interest in both domestic and international markets
Portfolio Companies
Reach CoSci Med-Tech Co. directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about CoSci Med-Tech Co.
What sectors does CoSci Med-Tech Co. invest in?
CoSci Med-Tech Co. invests in Pharmaceuticals, Medical Devices and Biotechnology, and is based in Beijing, China. CoSci Med-Tech Co. is listed as a corporate vc in the ConnectSafely investor database.
What stage does CoSci Med-Tech Co. invest at?
CoSci Med-Tech Co. backs companies at Seed, Early Stage, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does CoSci Med-Tech Co. invest in?
CoSci Med-Tech Co. invests across United States and China.
What companies has CoSci Med-Tech Co. invested in?
CoSci Med-Tech Co.'s portfolio includes JDP Therapeutics.
Last updated · Source: ConnectSafely investor database
